| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $49.0M | +19.1% |
| R&D Expense | $2.8M | +26.8% |
| Operating Income | $9.4M | +118.5% |
| Pre-tax Income | $9.8M | +122.2% |
| Income Tax | $2.1M | +134.8% |
| Net Income | $7.6M | +118.9% |
| EPS (Basic) | $2.78 | +115.5% |
| EPS (Diluted) | $2.65 | +107.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.6M | +223.1% |
| Accounts Receivable | $6.8M | +42.5% |
| Inventory | $9.5M | +7.0% |
| Current Assets | $29.8M | +63.6% |
| Total Assets | $36.5M | +50.1% |
| Current Liabilities | $5.2M | +19.0% |
| Total Liabilities | $5.2M | +18.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.5M | +70.7% |
| Capital Expenditures | $1.9M | +48.2% |
| Investing Cash Flow | -$1.9M | -48.2% |
| Financing Cash Flow | $3.1M | +2366.4% |
| Free Cash Flow | $5.6M | +80.0% |
| Stockholders' Equity |
| $31.3M |
| +57.2% |